Literature DB >> 9674446

Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors.

J F Regnard1, N Santelmo, N Romdhani, N Gharbi, J Bourcereau, E Dulmet, P Levasseur.   

Abstract

STUDY
DESIGN: To determine the long-term results after surgical treatment of bronchioloalveolar lung carcinoma (BALC) and to identify prognostic factors. PATIENTS AND METHODS: A retrospective study of 70 patients (49 men, 21 women), mean age 61+/-10 years, was carried out. Their carcinomas were classified into three clinicopathologic types: nodular or tumoral, pneumonic, and diffuse types. All the diagnosed BALC cases were reviewed and were classified into histologic types: mucinous, nonmucinous (including fibrotic center), and mixed tumors. Univariate and multivariate analyses were carried out.
RESULTS: The nodular or tumoral type was identified in 42 patients, pneumonic in 21, and diffuse in seven. Histologically, there were 36 mucinous, 25 nonmucinous, and nine mixed tumors. Resection was complete in 61 instances (87%) and incomplete in five. The 5-year survival rate was 34% in patients with curative resections. Five prognostic factors were identified by univariate analysis, but in multivariate analysis, only three factors remained significant: the absence of symptoms, the TNM stage, and completeness of resection. Thirty-six patients with curative resection (59%) developed recurrences (in the lung in 26 patients; mediastinal lymph nodes, four; distant metastases, nine). The frequency of recurrence was significantly greater in patients with pneumonic-type BALC than in nodular or tumoral types (p<0.01), and pulmonary recurrences were significantly more frequent in pneumonic than in tumoral types (p<0.02).
CONCLUSIONS: This study confirmed that the overall prognosis of BALC is not significantly different from that of the other non-small cell lung cancers. We found that the lungs are the predominant site of recurrence in BALC, especially in the pneumonic types. The complete surgical resection of localized BALC offers the best chances of long-term survival.

Entities:  

Mesh:

Year:  1998        PMID: 9674446     DOI: 10.1378/chest.114.1.45

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.

Authors:  Masashi Iwasaki; Shunta Ishihara; Satoru Okada; Reona Shimegi; Masanori Shimomura; Masayoshi Inoue
Journal:  Ann Surg Oncol       Date:  2022-06-02       Impact factor: 4.339

2.  High incidence of EGFR mutations in pneumonic-type non-small cell lung cancer.

Authors:  Jun Liu; Jianfei Shen; Chenglin Yang; Ping He; Yubao Guan; Wenhua Liang; Jianxing He
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

3.  TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.

Authors:  K Murakami; T Yamaura; K Suda; S Ohie; J Shibata; T Toko; Y Yamada; I Saiki
Journal:  Jpn J Cancer Res       Date:  1999-11

4.  Clinical characteristics and prognosis of nonsurgically treated patients with pneumonic-type adenocarcinoma.

Authors:  Jia Wei; Dezhu Tang; Ying Nie; Jie Chen; Li Peng
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.